Skip to main content

XTLB · Xtl Biopharmaceuticals Ltd · Debt

Track XTLB — free
$1.70 -0.03 (-1.45%) At close · Nov 4
Market Cap
$4.18M
Shares
2.46M
Volume · Nov 4 9546 Avg daily vol (3M) 8509

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Loans received 2025-12-31 USD 208,000 20-F filed 2026-06-30
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1023549 CUSIP 98386D406 13F (30d) 1 filings 1 filers Visit website Investor relations